Bijay Singh
Overview
Explore the profile of Bijay Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim Y, Park T, Singh B, Cho K, Sangshetti J, Choi Y, et al.
J Mater Chem B
. 2020 Apr;
4(15):2740.
PMID: 32263300
Correction for 'Efficient gene transfection to liver cells via the cellular regulation of a multifunctional polylactitol-based gene transporter' by Young-Dong Kim et al., J. Mater. Chem. B, 2016, 4, 2208-2218.
12.
Kim Y, Park T, Singh B, Cho K, Sangshetti J, Choi Y, et al.
J Mater Chem B
. 2020 Apr;
4(12):2208-2218.
PMID: 32263188
In recent years, the introduction of non-viral gene transfer systems for the treatment of inherited and acquired liver diseases has attracted a lot of attention. To facilitate liver-directed gene delivery,...
13.
Kunjachan S, Kotb S, Pola R, Pechar M, Kumar R, Singh B, et al.
Sci Rep
. 2019 Nov;
9(1):15844.
PMID: 31676822
Effective drug delivery is restricted by pathophysiological barriers in solid tumors. In human pancreatic adenocarcinoma, poorly-permeable blood vessels limit the intratumoral permeation and penetration of chemo or nanotherapeutic drugs. New...
14.
Rajendrakumar S, Mohapatra A, Singh B, Revuri V, Lee Y, Kim C, et al.
Polymers (Basel)
. 2019 Apr;
10(10).
PMID: 30960988
Malignant melanoma is a highly aggressive type of cancer that requires radical treatment strategies to inhibit the cancer cell progression and metastasis. In recent years, preclinical research and clinical trials...
15.
Singh B, Mitragotri S
Biotechnol Adv
. 2019 Jan;
42:107339.
PMID: 30639928
Clinical translation of nanoparticle drug (nanodrug) delivery systems for cancer therapy is primarily hindered by short half-life of nanodrugs in blood circulation and their poor ability of tumor targeting and...
16.
Lee H, Yoon S, Singh B, Oh S, Cui L, Yan C, et al.
Tissue Eng Regen Med
. 2019 Jan;
15(1):1-11.
PMID: 30603530
Several barriers such as gastric pH, enzymatic degradation and rapid transit should be overcome to orally deliver antigens for taking up by epithelial microfold cells in Peyer's patches of small...
17.
Cho K, Singh B, Maharjan S, Jang Y, Choi Y, Cho C
Tissue Eng Regen Med
. 2019 Jan;
14(3):211-220.
PMID: 30603478
Healing process in scarring inevitably produces a considerable amount of non-organized dense collagen-rich matrix called scar thus impairing the native structure of skin. Connective tissue growth factor (CTGF) overexpression within...
18.
Kim Y, Pofali P, Park T, Singh B, Cho K, Maharjan S, et al.
Tissue Eng Regen Med
. 2019 Jan;
13(2):111-125.
PMID: 30603391
Gene therapy holds a great promise and has been extensively investigated to improve bone formation and regeneration therapies in bone tissue engineering. A variety of osteogenic genes can be delivered...
19.
Singh B, Maharjan S, Sindurakar P, Cho K, Choi Y, Cho C
Int J Mol Sci
. 2018 Nov;
19(11).
PMID: 30463211
Despite successful use, needle-based immunizations have several issues such as the risk of injuries and infections from the reuse of needles and syringes and the low patient compliance due to...
20.
Pi Q, Maharjan S, Yan X, Liu X, Singh B, van Genderen A, et al.
Adv Mater
. 2018 Aug;
30(43):e1706913.
PMID: 30136318
Despite advances in the bioprinting technology, biofabrication of circumferentially multilayered tubular tissues or organs with cellular heterogeneity, such as blood vessels, trachea, intestine, colon, ureter, and urethra, remains a challenge....